Syndax
Oncology Therapeutics
7open roles
$235kmedian advertised pay
5cities with offices
11stories in the press
Overview
Syndax is a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, with the aim that people with cancer live longer and better. Its postings cover oncology account managers in San Francisco and San Diego, regulatory strategy leadership and contractors in legal, clinical data and statistical programming. The company is headquartered in New York, United States.
Key facts
As of Nov 13, 2026, Alion lists 7 open roles at Syndax. Syndax is headquartered in New York, United States. The median pay stated in its open roles is $235k, across 6 postings that state pay.
- Open roles
- 7Its careers board, read on Nov 13, 2026
- Headquarters
- New York, United StatesAlion company profile, updated Nov 12, 2026
- Median advertised pay
- $235kPay stated in 6 open postings
- Technologies in its job postings
- 7Named in its job postings
Official records
Jobs
Apply
$270k – $290k per year · In office · 10+ years exp · Bachelor's Degree · New York
Apply
$235k – $260k per year · Remote (United States) · 5+ years exp · Master's Degree · New York
SAS
Good Clinical Practice
Apply
Salary insights
Compensation ranges based on this company's open jobs
Median
$235k
Typical range
$165k – $290k
Open positions
7
7
Jobs
Senior
57.1%
Architect
42.9%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Senior | 4 | $235k | $165k – $290k |
| Architect | 3 | $215k | $210k – $260k |
Highest paying role
Senior Director, Alliance Management
$290k
Normalized to USD per year
All salaries at Syndax
By role, level and city, against the market · 7 jobs with pay
Growth
Hiring Momentum
44/100
Stable
Open positions
7
0 opened / 6 closed in 30 days
Median time-to-fill
45 days
faster than 30% of the market
ATS activity
Every ~6 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Early Careers
26% ▼
Marketing
16% ▲
Operations
16% ▲
Biotech
16% ▼
Legal
5% ▼
Sales
5% ▼
Activity Timeline
Added Good Clinical Practice to stack
Oct 2026
Added CDISC to stack
Oct 2026
Added GMP to stack
Oct 2026
Added CAPA to stack
Oct 2026
New location: Phoenix
Oct 2026
New location: San Diego
Oct 2026
New location: San Francisco
Oct 2026
Added Windows to stack
Sep 2026
Added Microsoft Office to stack
Sep 2026
Tech stack
Technologies named in job postings at Syndax over the last 12 months, by layer, with the share of postings for each.
Technologies in use
7
Postings analysed
8
Stack modernity
58/100
Languages
SAS
Cloud & platforms
GCP
Windows
Practices & domains
CAPA
GMP
CDISC
Good Clinical Practice
Sign in to see how your skills match this stack
Sign In
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on September 1, 2026, the Company granted inducement awards to pur
Read more
Report
Syndax (SNDX) Sales Nearly Doubled, So Why Did The Stock Fall?
Syndax Pharmaceuticals (NASDAQ:SNDX) just posted a quarter that nearly doubled revenue, yet shares slipped 2.41% anyway. On its August 4 earnings call, management reported combined sales of $115 million across its two approved drugs, both now annualizing
Read more
Report
Syndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innova...
Read more
Report
uniQure, Syndax and Erasca Are Drawing Analyst Interest Ahead of Key Drug Catalysts
Wall Street is turning constructive on three clinical-stage biotechs simultaneously, each sitting at the edge of a binary catalyst. The analyst calls on uniQure (NASDAQ:QURE), Syndax Pharmaceuticals (NASDAQ:SNDX), and Erasca (NASDAQ:ERAS) share a common t
Read more
Report
Syndax Pharmaceuticals (SNDX) Gets a Buy from Citi
Detailed price information for Syndax Pharma (SNDX-Q) from The Globe and Mail including charting and trades.
Read more
Report
Syndax projects $750M market opportunity for Revuforj driven by new launches and label expansions
Read more
Report
Syndax Pharmaceuticals Stock Falls After Data From Mid-Stage Study Of Revumenib In Form Of Blood Cancer
Read more
Report
Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors
--Syndax Pharmaceuticals, a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the appointment of Aleksandra Rizo, M.D., Ph.D., to its Board of Directors. She will serve as a member of the Scien
Read more
Report
Offices
Where the company hires and what each office is for
Cities
5
Hiring now
3
Countries
1
Busiest office
New York
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
New York
United States
HQ
New York
5 open roles 19 posted in 90 days 20% remote $228k Avg Salary
hires for Operations, Sales, Biotech
San Francisco
United States
Field-Based
1 open roles 1 posted in 90 days $235k Avg Salary
hires for Marketing
Phoenix
United States
Field-Based
1 open roles 100% remote $235k Avg Salary
hires for Marketing
Waltham
United States
Regional office
Waltham
Manhattan
United States
Regional office
New York
Earlier presence
San Diego, United States
How to cite this page
Alion, "Syndax: key facts", as of Nov 13, 2026. https://alion.io/company/syndax
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0